- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Pricing Information: Rx Web sites are hit and miss
Patients are generally poorly served by the drug-price-comparison websites that promise to help them, according to a study released by the Center for Studying Health System Change.
Patients are generally poorly served by the drug-price-comparison Web sites that promise to help them, according to a study released by the Center for Studying Health System Change (HSC). The problem? All but one of the 10 states HSC studied use Medicaid pharmacy claims data, which often contain usual and customary price information. Those data are usually relevant only to the uninsured. Insured patients generally pay lower prices because a pharmacy benefit manager is negotiating on their behalf. Moreover, since the states don't require pharmacies to report pricing information, the number of drugs posted on each Web site varied widely, from as few as 26 in Maryland to 400 in Minnesota.
